# A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

> **NCT01559545** · PHASE2 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 60 (actual)

## Conditions studied

- Clostridium Difficile Associated Diarrhea

## Interventions

- **DRUG:** Metronidazole
- **DRUG:** Metronidazole-DRF1
- **DRUG:** Metronidazole-DRF2

## Key facts

- **NCT ID:** NCT01559545
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-02
- **Final completion:** 2013-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01559545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01559545, "A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01559545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*